1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Minnesota >
  6. Immusoft Acquires Discovery Genomics

M&A Deal Summary

Immusoft Acquires Discovery Genomics

On March 8, 2016, Immusoft acquired life science company Discovery Genomics

Acquisition Highlights
  • This is Immusoft’s 1st transaction in the Life Science sector.
  • This is Immusoft’s 1st transaction in the United States.
  • This is Immusoft’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2016-03-08
Target Discovery Genomics
Sector Life Science
Buyer(s) Immusoft
Deal Type Add-on Acquisition

Target

Discovery Genomics

Minneapolis, Minnesota, United States
Discovery Genomics, Inc. is a provider of gene therapies for blood diseases.

Search 205,859 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Immusoft

Seattle, Washington, United States
Category Company
Founded 2009
Sector Information Technology
DESCRIPTION

Immusoft Corp. is a developer of a breakthrough autologous cell therapy platform for treating a variety of human diseases through proprietary Immune System Programming (ISP™) technology.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal